KALA BIO, Inc.
KALA
$9.31
$0.536.04%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.64M | 4.59M | 4.20M | 4.40M | 4.32M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.88M | 10.65M | 9.46M | 9.57M | 9.63M |
| Operating Income | -10.88M | -10.65M | -9.46M | -9.57M | -9.63M |
| Income Before Tax | -11.16M | -8.95M | -8.18M | -8.95M | -9.58M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.16M | -8.95M | -8.18M | -8.95M | -9.58M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.16M | -8.95M | -8.18M | -8.95M | -9.58M |
| EBIT | -10.88M | -10.65M | -9.46M | -9.57M | -9.63M |
| EBITDA | -10.81M | -10.58M | -9.39M | -9.51M | -9.57M |
| EPS Basic | -1.71 | -1.41 | -1.74 | -1.93 | -3.16 |
| Normalized Basic EPS | -1.06 | -0.88 | -1.09 | -1.15 | -1.98 |
| EPS Diluted | -1.71 | -1.41 | -1.74 | -1.93 | -3.16 |
| Normalized Diluted EPS | -1.06 | -0.88 | -1.09 | -1.15 | -1.98 |
| Average Basic Shares Outstanding | 6.51M | 6.35M | 4.69M | 4.63M | 3.03M |
| Average Diluted Shares Outstanding | 6.51M | 6.35M | 4.69M | 4.63M | 3.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |